As VP of Regulatory Strategy & Policy for Synchrogenix and Principal Attorney at the Kulkarni Law Firm, Dr. Kulkarni provides corporate and regulatory legal advice. He has experience in corporate quality control and regularly performs varying legal and regulatory functions, including crafting responses to FDA titled and untitled letters, reviewing potential ads, and negotiating with and for advertising agencies and scientific writing agencies. As an FDA attorney and product development consultant, he focuses on strategic regulatory and pharmaceutical counseling and has extensive experience handling the needs of international pharmaceutical, biopharmaceutical, and medical device companies and their service providers.
Twitter: https://twitter.com/DarshanTalks
Website: https://www.kulkarnilawfirm.com/
